A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability
Maurice A.G.M. Kroon(Amsterdam University Medical Centers), E. Marleen Kemper(Amsterdam University Medical Centers), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Olaf van Tellingen(Dutch Cancer Society), Eleonora L. Swart(Amsterdam University Medical Centers)
Cited by 38
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884